{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T13:00:36Z","timestamp":1780146036225,"version":"3.54.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study evaluates the effect of resection margin distance on disease-free survival (DFS) and (local) recurrence rates in patients with vulvar squamous cell carcinoma (SCC) while assessing the impact of associated factors such as lichen sclerosus (LS) and lymph node metastasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective single-center analysis was conducted on 150 patients treated for vulvar SCC between 2004 and 2014 at University Hospital D\u00fcsseldorf. Univariate and multivariate regression analyses were performed to evaluate the impact of clinical and pathological factors on DFS. Additionally, a literature review was conducted to summarize existing evidence on resection margins.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The findings suggest that a resection margin exceeding 8\u00a0mm does not significantly improve DFS (HR 1.14, CI 1.01\u20131.28, <jats:italic>p\u00a0<\/jats:italic>=\u00a00.029). LS was significantly associated with recurrence (HR 2.36, CI 1.13\u20134.91, <jats:italic>p\u00a0<\/jats:italic>=\u00a00.02) and reduced DFS. Univariate analysis identified lymph node metastasis as a significant predictor of DFS; however, this association was not retained in multivariate analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Although current guidelines advocate for resection margins &gt;8\u00a0mm, our findings suggest that smaller margins may be acceptable in selected patients, particularly those without LS and tumors located near critical structures (e.g., the anus, clitoris, or urethra). These considerations should inform personalized treatment strategies and follow-up care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00404-025-08046-y","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:16:47Z","timestamp":1747815407000},"page":"611-620","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Influence of resection distance on vulvar cancer relapse: a retrospective analysis"],"prefix":"10.1007","volume":"312","author":[{"given":"Jan-Philipp","family":"Cieslik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Sophia","family":"Beerbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hampl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"8046_CR1","unstructured":"Global cancer observatory: cancer today (version 1.1)"},{"key":"8046_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.6004\/jnccn.2024.0013","volume":"22","author":"NR Abu-Rustum","year":"2024","unstructured":"Abu-Rustum NR et al (2024) Vulvar cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22:117\u2013135","journal-title":"J Natl Compr Canc Netw"},{"key":"8046_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","volume":"38","author":"JM Heaps","year":"1990","unstructured":"Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS (1990) Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38:309\u2013314","journal-title":"Gynecol Oncol"},{"key":"8046_CR4","first-page":"1159","volume":"100","author":"R Rouzier","year":"2002","unstructured":"Rouzier R (2002) Local relapse in patients treated for squamous cell vulvar carcinoma Incidence and prognostic value. Obstet Gynecol 100:1159\u20131167","journal-title":"Obstet Gynecol"},{"key":"8046_CR5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(98)08228-2","volume":"353","author":"J Powell","year":"1999","unstructured":"Powell J, Wojnarowska F (1999) Lichen sclerosus. Lancet 353:1777\u20131783","journal-title":"Lancet"},{"key":"8046_CR6","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/ijc.30621","volume":"140","author":"P Halonen","year":"2017","unstructured":"Halonen P et al (2017) Lichen sclerosus and risk of cancer. Int J Cancer 140:1998\u20132002","journal-title":"Int J Cancer"},{"key":"8046_CR7","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/cncr.10969","volume":"95","author":"JA De Hullu","year":"2002","unstructured":"De Hullu JA et al (2002) Vulvar carcinoma: the price of less radical surgery. Cancer 95:2331\u20132338","journal-title":"Cancer"},{"key":"8046_CR8","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ygyno.2006.10.004","volume":"104","author":"JK Chan","year":"2007","unstructured":"Chan JK et al (2007) Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 104:636\u2013641","journal-title":"Gynecol Oncol"},{"key":"8046_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"8046_CR10","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/cancers15164110","volume":"15","author":"FA Taran","year":"2023","unstructured":"Taran FA et al (2023) Tumor-free resection margin distance in the surgical treatment of node-negative squamous cell cancer of the vulva has no impact on survival: analysis of a large patient cohort in a tertiary care center. Cancers 15:4110","journal-title":"Cancers"},{"key":"8046_CR11","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.3390\/cancers12113375","volume":"12","author":"EL Barlow","year":"2020","unstructured":"Barlow EL, Jackson M, Hacker NF (2020) The prognostic role of the surgical margins in squamous vulvar cancer: a retrospective australian study. Cancers 12:3375","journal-title":"Cancers"},{"key":"8046_CR12","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.ejso.2019.07.005","volume":"45","author":"E Raimond","year":"2019","unstructured":"Raimond E et al (2019) Surgical treatment of vulvar cancer: Impact of tumor-free margin distance on recurrence and survival. A multicentre cohort analysis from the francogyn study group. Eur J Surg Oncol 45:2109\u20132114","journal-title":"Eur J Surg Oncol"},{"key":"8046_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ygyno.2019.05.010","volume":"154","author":"NC Te Grootenhuis","year":"2019","unstructured":"Te Grootenhuis NC et al (2019) Margin status revisited in vulvar squamous cell carcinoma. Gynecol Oncol 154:266\u2013275","journal-title":"Gynecol Oncol"},{"key":"8046_CR14","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.ejso.2018.05.031","volume":"44","author":"N Pleunis","year":"2018","unstructured":"Pleunis N et al (2018) Surgical margins in squamous cell carcinoma, different for the vulva? Eur J Surg Oncol 44:1555\u20131561","journal-title":"Eur J Surg Oncol"},{"key":"8046_CR15","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e61","volume":"29","author":"L Micheletti","year":"2018","unstructured":"Micheletti L et al (2018) Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB\/II vulvar squamous cell carcinoma. J Gynecol Oncol 29:e61","journal-title":"J Gynecol Oncol"},{"key":"8046_CR16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejca.2016.09.038","volume":"69","author":"L Woelber","year":"2016","unstructured":"Woelber L et al (2016) Role of tumour-free margin distance for loco-regional control in vulvar cancer\u2014a subset analysis of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie CaRE-1 multicenter study. Eur J Cancer 69:180\u2013188","journal-title":"Eur J Cancer"},{"key":"8046_CR17","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ejso.2015.09.024","volume":"41","author":"G Baiocchi","year":"2015","unstructured":"Baiocchi G et al (2015) How important is the pathological margin distance in vulvar cancer? Eur J Surg Oncol EJSO 41:1653\u20131658","journal-title":"Eur J Surg Oncol EJSO"},{"key":"8046_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3802\/jgo.2013.24.3.242","volume":"24","author":"S Iacoponi","year":"2013","unstructured":"Iacoponi S, Zapardiel I, Diestro MD, Hernandez A, De Santiago J (2013) Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva. J Gynecol Oncol 24:242","journal-title":"J Gynecol Oncol"},{"key":"8046_CR19","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1245\/s10434-011-1778-0","volume":"18","author":"L Woelber","year":"2011","unstructured":"Woelber L et al (2011) Prognostic value of pathological resection margin distance in squamous cell cancer of the vulva. Ann Surg Oncol 18:3811\u20133818","journal-title":"Ann Surg Oncol"},{"key":"8046_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/IGC.0b013e3181df7423","volume":"20","author":"SMA Groenen","year":"2010","unstructured":"Groenen SMA, Timmers PJ, Burger CW (2010) Recurrence rate in vulvar carcinoma in relation to pathological margin distance. Int J Gynecol Cancer 20:869\u2013873","journal-title":"Int J Gynecol Cancer"},{"key":"8046_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0090-8258(90)90067-U","volume":"38","author":"TW Burke","year":"1990","unstructured":"Burke TW et al (1990) Radical wide excision and selective inguinal node dissection for squamous cell carcinoma of the vulva. Gynecol Oncol 38:328\u2013332","journal-title":"Gynecol Oncol"},{"key":"8046_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/IGC.0000000000001195","volume":"28","author":"M Arvas","year":"2018","unstructured":"Arvas M et al (2018) The role of pathological margin distance and prognostic factors after primary surgery in squamous cell carcinoma of the vulva. Int J Gynecol Cancer 28:623\u2013631","journal-title":"Int J Gynecol Cancer"},{"key":"8046_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.5603\/GP.a2018.0073","volume":"89","author":"L Minar","year":"2018","unstructured":"Minar L, Felsinger M, Cihalova M, Zlamal F, Bienertova-Vasku J (2018) Vulvar cancer recurrence: an analysis of prognostic factors in tumour-free pathological margins patients group. Ginekol Pol 89:425\u2013432","journal-title":"Ginekol Pol"},{"key":"8046_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/jog.14368","volume":"46","author":"B Pecorino","year":"2020","unstructured":"Pecorino B et al (2020) Prognostic factors and surgical treatment in vulvar carcinoma: single center experience. J Obstet Gynaecol Res 46:1871\u20131878","journal-title":"J Obstet Gynaecol Res"},{"key":"8046_CR25","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1111\/jog.14962","volume":"47","author":"H Nomura","year":"2021","unstructured":"Nomura H et al (2021) Positive surgical margin is an independent predictor of overall survival of patients with vulvar squamous cell carcinoma. J Obstet Gynaecol Res 47:3990\u20133997","journal-title":"J Obstet Gynaecol Res"},{"key":"8046_CR26","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","volume":"151","author":"A Lee","year":"2015","unstructured":"Lee A, Bradford J, Fischer G (2015) Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol 151:1061","journal-title":"JAMA Dermatol"},{"key":"8046_CR27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","volume":"33","author":"MHM Oonk","year":"2023","unstructured":"Oonk MHM et al (2023) European society of gynaecological oncology guidelines for the management of patients with vulvar cancer-update 2023. Int J Gynecol Cancer 33:1023\u20131043","journal-title":"Int J Gynecol Cancer"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08046-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08046-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:12:05Z","timestamp":1757171525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08046-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["8046"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08046-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been updated to amend the license information","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Fehm has received consulting fees from Amgen, Daiichi Sankyo, Roche, AstraZeneca, MSD Oncology, Novartis, Pierre Fabre, Pfizer, and Teva; received fees for non-CME services received directly from commercial interest or their agents from Daichi Sankyo, Roche, and Novartis. M. Hampl has received speaker honoraria and travel cost reimbursements from MSD, Astra Zeneca, Exeltis, Gedeon Richter, Amedes and Sanofi.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}